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ABSTRACT 
Nature has been a wellspring of therapeutic for a vast number of years and a great number of present day drugs have been separated 
from plant resources. It has been evaluated that natural prescriptions serve around 80% of the total population wellbeing requirement 
for many individuals throughout the world. Cissus quadrangularis a member of the family Vitaceae, Cardiospermum halicacabum 
and Dodonea viscosa members of the family Sapindaceae are well known for its utilization in the treatment of skin contaminations, 
blockage, piles, lack of health, weight loss, ant-inflammatory, anti-ulcer and bone crack healing. In the present study, based on GC-
MS methanolic extract of stem and leaf of these three plants showed and identified fifteen major compounds with pharmacological 
activities. The FT-IR analysis showed similar functional groups of compounds related their medicinal properties such as Bone 
healing and wound healing activities. 
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INTRODUCTION  
Traditional Indian Medicine (TIM) is a noteworthy 
wellspring of possibly valuable new constituent for the 
improvement of chemotherapeutic specialists
 1
. It has 
been evaluated that natural prescriptions serve around 
80% of the total worldwide population
 2
. The utilization 
of plants in the administration and treatment of 
sicknesses and natural products are considered 
organically dynamic mixes. Cissus quadrangularis L, 
belong to the family Vitaceae and distributed in India, 
Sri Lanka, Malaysia, Thailand and Africa. The stem 
portion of C. quadrangularis is utilized for the treatment 
of skin contaminations, blockage, heaps, frailty, asthma,  
sporadic feminine cycle, consumes, wounds and anti-
ulcer
3
 anti-oxidant, hostile to malignancy activity
4
, 
microbial activities
5
, against osteoporotic activity
6
, 
weight loss
7
, ant-inflammatory
8
 and bone crack healing
9
. 
Cardiospermum halicacabum belong to with the family 
Sapindaceae is a climber. These two species are widely 
distributed in tropical and subtropical Asia and Africa 
10
. 
The entire plant has been used in the treatment of 
stiffness, lumbago, diuretic, stomachic, ear infection, 
cough, emetic, purgative and rheumatic. The seeds are 
utilized a diaphoretic
 11
, anti-malarial
 12
, anti-oxidant and 
anti-inflammatory
 13,14
. C. halicacabum roots have been 
utilized for the treatment of epilepsy and tension 
disorders
 15
. D. viscosa is placed in the family 
Sapindaceae and distributed in India and Nepal. It is 
utilized for different therapeutic purposes such as 
diuretic, anti‐inflammatory, anti‐ulcer 16-17, snake bites 18 
and anti-oxidant
 19
.  
This study is mainly focus on to compare the divergence 
of biological compounds identification investigated by 
GC-MS and FT-IR analyses. GC-MS investigation was 
made by a typical library search (NIST, WILEY) and 
literature comparison and the biological activities of 
these compounds were studied for possible drug 
development of active compounds. 
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MATERIALS AND METHODS 
Collection and preparation of plant material 
The plants were collected from natural habitats and the 
herbarium specimen of the same was prepared and 
deposited in the Department of Botany, Annamalai 
University with the accession number for C. 
quadrangularis (AUBOT343), C. halicacabum 
(AUBOT347) and D. viscosa (AUBOT340). The plants 
were washed completely in running tap water to remove 
soil particles and the plant parts were separated and 
shade dried. The shade dried plant parts were separately 
and stored in air tight container for further analysis. 
Chemicals 
The chemicals were obtained from Himedia, Mumbai, 
India and the solvents used were of phytochemical 
analyses  
Equipment 
Equipment’s used on this experiment consist of GC-MS 
and FT-IR. GC-MS was used for the identity of 
compounds in samples and FT-IR becomes used for 
identification of functional agencies provided within the 
species of C. quadrangularis, D. viscosa and C. 
halicacabum. 
Plant sample extraction 
Shade dried and powdered plant materials were 
successively extracted with methanol with gentle stirring 
for 72 hours. The extraction were passed through 
Whatmann No. 1 paper and collected. 
Gas Chromatography- Mass Spectrum Analysis 
(GC-MS) 
25 gm of the stem and leaves powder C. quadrangularis, 
C. halicacabum and D. viscosa were soaked in 95 % 
methanol for 12 hours. The extracts were then filtered 
through Whatmann filter No. 1 along with 2 gm Sodium 
sulphate to remove the sediments and traces of water in 
the filtrate. Then the filtrate was concentrated by 
introducing bubbling nitrogen gas into the solution. The 
plant extract contains both polar and non-polar 
phytochemicals. 2 µl of the plant methanolic extract 
filtrate was used for GC-MS analysis. GC-MS analysis 
of the methanolic extract of the plant samples taken for 
this study was performed by using a Perkin- Elmer GC 
clarus- 500 system comprising an AOC 20C auto 
sampler and a Gas chromatograph intergraded to a mass 
spectrometer equipped with Elite – 5MS fused capillary 
column. Helium gas was used as a carrier gas at a 
constant flow rate of 1 ml/min, and an injector where of 
2 µl was employed. The inject temperature was 
maintained at 250C, the ion source temperature was 
200C and oven temperature was programmed from 
110C, with an increase of 10C/min to 200C, then 
5C/min 280C ending with a 9 min isothermal at 
280C. The solvent delay was 0 to 2 min, and the total 
GC/MS running time was 36 min. The relative 
percentage amount of each component was calculated by 
comparing its average peak area to the total areas. The 
Mass detector used in this analysis was turbo- Mass gold 
Perkin- Elmer and the software adopted to handle Mass 
spectra and chromatogram was a Turbo – Mass Ver.5.2.    
FT-IR analysis 
The FT-IR analysis was done by utilizing Perkin Elmer 
Spectrum Version 10.03.09 framework, which was 
utilized to identify the practical gatherings of the 
compound. A little measure of concentrate was set 
specifically on the zinc solenoid piece and consistent 
weight. Information of infrared retentive, gathered over 
the wave number extended from 4000 cm
-1
 to 400 cm
-1
 
utilizing spectra programming. Tests were keep running 
in triplicate and every one of them were embraced inside 
a day time span. 
RESULTS AND DISCUSSION    
GC-MS 
The phytochemical constituents present in the stem 
methanolic extract of C. quadrangularis showed fifty 
four constituents. Out of these fifty four constituents five 
constituents were majorly present such as 3-O-Methyl-
D-glucose, D-Allose, 9,12,15-Octa decatrienoic acid, 
Phytol and Pentadecanoic Acid. Based on GC-MS 
spectrum confirmed the compounds with retention time 
23.574, 19.237, 28.706, 25.037and 26.250 respectively 
(Figure 1). Apart from the above mentioned compounds, 
the 3-O-Methyl-D-glucose was containing the 
percentage of 51.85 and it was identified as active 
compound of the species C. quadrangularis. The 
molecular formula of the compound was C7H14O6 (Table 
1).
 
 
Figure 1: GC-MS Chromatogram of methanolic Stem extract of C. quadrangularis 
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Table 1: GC-MS report of methanolic Stem extract of C. quadrangularis 
Peak 
 
R. 
Time Area% 
Name of the compounds Molecular 
formula 
Molecular 
weight 
1 5.910 1.48 1H-Pyrrole C4H5N 67 
2 11.910 0.32 2,3-Dihydro-3,5-Dihydroxy-6-Methyl-4h-Pyran-One C6H8O4 144 
3 13.630 0.31 2h-Pyran-2-One, 5,6-Dihydro-6-Pentyl- C10H16O2 168 
4 15.895 0.12 2.Alpha.,7,8-trimethylacenaphthylene C15H24 204 
5 16.439 0.04 
2-(3-Isopropyl-4-Methyl-3-Penten-1-Ynyl)-2-
Methycyclobutanone 
C14H20O 204 
6 16.663 0.04 3,6,6,7-Tetramethyl-3-Vinyl-2,3,3a,4,5,6-Hexahydro-1h-Indene C15H24 204 
7 16.753 0.25 
Tricyclo[4.4.0.0(2,7)]Dec-3-Ene, 1,3-Di Methyl -8-(1-
Methylethyl) 
C15H24 204 
8 17.281 0.04 Aromadenrene C15H24 204 
9 17.635 0.36 Trans (.beta.)-caryophyllene C15H24 204 
10 17.689 0.07 Isoledene C15H24 204 
11 18.272 0.11 1,4,8-Cycloundecatriene ,2,6,6,9-Tetra Methyl C15H24 204 
12 18.412 0.09 1H-Cycloprop [E]Azulene,  C15H24 204 
13 18.634 0.10 6.Alpha.-Cadina-4,9-Diene, (-)- C15H24 204 
14 18.762 0.20 Beta.-ylangene C15H24 204 
15 19.237 9.28 D-Allose C6H12O6 180 
16 20.443 0.03 1-Tridecanol C13H28O 200 
17 20.622 0.31 (-)-5-Oxatricyclo [8.2.0.0(4,6)]Dodecane,,  C15H24O 220 
18 21.064 0.05 Humulene Oxide C15H24O 220 
19 21.837 0.07 
(1ar-(1aalpha, 5abeta, 9ar(*)))-5a,9,9-
Trimethyloctahydrobenzo(D)Cycloprop(C)Oxepin-2,4 
C14H20O3 236 
20 23.574 51.85 3-O-Methyl-d-glucose C7H14O6 194 
21 24.406 1.55 2,6,10-Trimethyl,14-Ethylene-14-Pentadecne C20H38 278 
22 24.765 2.15 Neophytadiene C20H38 278 
23 25.037 3.41 Phytol  C20H40O 296 
24 25.654 0.37 Hexadecanoic Acid,  C17H34O2 270 
25 25.993 0.05 Isophytol C20H40O 296 
26 26.250 3.39 Pentadecanoic Acid C15H30O2 242 
27 26.628 0.08 14B-Pregnane C21H36 288 
28 27.597 0.05 Methyl 4-o-benzyl-.alpha.-l-rhamnopyra noside C14H20O5 268 
29 27.690 0.04 1H-Indene, 3-Methyl- C10H10 130 
30 28.116 0.63 9,12,15-Octadecatrie noic Acid, (Z,Z,Z)- C19H32O2 292 
31 28.294 2.72 3,7,11,15-Tetramethyl-, [R-[R*,R*-(E)]] C20H40O 296 
32 28.706 3.83 9,12,15-Octadecatrienoic Acid,  C18H30O2 278 
33 29.672 2.93 Cyclohexanol, 4-[(Tri Methylsilyl) Oxy] -, Cis- C9H20O2 188 
34 30.015 0.25 Decanoic Acid C10H20O2 172 
35 30.422 0.20 Octanoic acid, 2-di methylaminoethyl ester C12H25NO2 215 
36 30.630 0.33 5-Phenyl-Pentanoic Acid, Ethyl Ester C17H24O5 308 
37 32.423 0.42 Fumaric acid, 2-di methyl aminoethylnonyl ester C17H31NO4 313 
38 32.610 0.06 3-Cyclopentylpropionic Acid,  C12H23NO2 213 
39 32.715 0.13 2-Ethylbutyric Acid, Eicosyl Ester C26H52O2 396 
40 34.397 0.10 1-Penten-3-One, 4-Methyl-1-Phenyl- C12H14O 174 
41 34.562 0.20 Ethyl linolate C19H32O2 292 
42 36.408 0.79 Squalene C30H50 410 
43 36.914 0.18 TriacontylPentafluoropropionate C33H61F5O2 584 
44 38.909 0.15 Chol-5-ene-3,24-diol C24H40O2 360 
45 39.715 0.30 Ergost-5-En-3-Ol, (3.Beta.)- C28H48O 400 
46 40.396 0.89 Gamma.-tocopherol C28H48O2 416 
47 40.854 0.10 5-chlorostigmastan-3-yl acetate C31H53C1O2 492 
48 41.626 0.42 Stigmast-5-En-3-Ol, (3.Beta.)- C29H50O 414 
49 42.318 2.70 Vitamin E C29H50O2 430 
50 45.092 0.40 24- Epicampesterol C28H48O 400 
51 46.073 1.05 Stigmasta-5,22-Dien-3-ol C29H48O 412 
52 47.994 0.52 Beta-di hydrofucosterol C29H50O 414 
53 49.254 1.50 ,14,14a,14b-Octadbctadecahyro-2h-Picen-3-One C30H48O 424 
54 51.398 2.98 D:B-Friedo-B':A'-Neogammacer-5-En-3-one C30H48O 424 
  100.00    
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GC-MS analysis of Methanolic extract of C. 
halicacabum leaves demonstrates nearness of forty two 
constituents. Out of these forty two constituents five 
constituents were majorly present such as Calix[4]arene, 
Epi-Psi-Taraxastanonol, Beta-Sitosterol, Tetradecanoic 
corrosive and Iso Longifolol with their respective 
retention time such as 43.196, 50.113, 48.078, 23.291 
and 56.873 respectively (Figure 2). Based on the 
spectrum percentage area, Calix[4]arene (24.85) was 
identified as major active compound and the molecular 
formula was C28H24O4 (Table 2).  
 
 
Figure 2: GC-MS Chromatogram of methanolic Leaf extract of C. halicacabum 
 
Table 2: GC-MS report of methanolic Leaf extract of C. halicacabum 
Peak 
 
R. 
Time 
Area% 
 
Name of the compounds Molecular 
formula 
M.W. 
1 20.090 0.25 Dodecanoic acid C12H24O2 200 
2 20.310 0.15 Glutaric acid, 2-(4-fluorophenyl)ethyl 2-methylhex-3-yl ester C20H29FO4 352 
3 20.371 0.15 1,2-Benzenedicarboxy lic acid,bis(2-methyl propyl) ester C16H22O4 278 
4 20.634 0.12 1,2-Benzenedicarboxy lic acid, diethyl ester C12H14O4 222 
5 23.291 3.88 tetradecanoic acid C14H28O2 228 
6 24.395 0.49 2,6,10-Trimethyl,14-ethylene-14-pentadecne C20H38 278 
7 24.497 0.17 2-Pentadecanon, 6,10,14-trimethyl- C18H36O 268 
8 24.762 1.18 Neophytadine C20H38 278 
9 25.033 1.95 3,7,11,15-Tetramethyl-2-hexadecen-1-ol,3,7,11,15-tetramethyl C20H40O 296 
10 25.655 0.31 Hexadecanoic acid, methyl ester C17H34O2 270 
11 26.234 3.76 Pentadecanoic acid C15H30O2 242 
12 27.600 0.21 9-Octadecenoic acid (z)  C18H34O2 282 
13 28.020 0.15 9,12-Octadecadienoic acid, methyl ester C19H34O2 294 
14 28.110 0.25 9,12,15-Octadecatrienoic acid, methyl ester, (z,z,z)- C19H32O2 292 
15 28.303 1.02 Phytol isomer C20H40O 296 
16 28.409 0.21 Tetradecanoic acid, methyl ester C15H30O2 242 
17 28.583 0.29 9,12-Octadecadienoic acid (z,z)- C18H32O2 280 
18 28.640 1.49 Cis-vaccenic acid C18H34O2 282 
19 28.917 1.02 Octadecanoic acid C18H36O2 284 
20 31.358 0.32 Eicosanoic acid C20H40O2 312 
21 33.119 0.55 1,2-Benzene di carboxylic acid C24H38O4 390 
22 33.268 0.17 Bis(2- Ethylhexyl) Phthalate C24H38O4 390 
23 36.404 0.68 Squalene C30H50 410 
24 38.905 0.53 Beta –sitosterin C29H50O 414 
25 39.749 0.72 24-Epicampesterol  C28H48O 400 
26 40.426 0.97 Gamma.-tocopherol C28H48O2 416 
27 40.850 0.81 Fucosterol, beta- dihydro C29H50O 414 
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28 
 41.626 3.10 Stigmast-5-en-3-ol, oleate 
C47H82O2 678 
29 42.303 0.56 Vitamin E C29H50O2 430 
30 43.196 24.85 Calix[4]arene  ‎C28H24O4 424 
31 45.166 0.96 Ergost-5-en-3-ol, (3.beta.,24r)- C28H48O 400 
32 47.649 0.49 D-Friedoolean-14-en-3-one C30H48O 424 
33 48.078 5.68 Beta-Sitosterol C29H50O 414 
34 48.364 2.66 4,4,6a,6b,8a,11,11,14b-Octamethyl-1,4,4a,5,6,6a, 6b C30H48O 424 
35 49.336 3.24 tetramethyltricyclo[5.4.0.0(4,11)] C16H28O 236 
36 50.113 18.24 Epi-.Psi.- Taraxastanonol C30H50O2 442 
37 51.012 2.67 Methyl commate D C31H50O4 486 
38 51.585 3.86 D:A-Friedoolean-6-ene C30H50 410 
39 53.267 3.21 Stigmast-4-en-3-one C29H48O 412 
40 54.508 2.30 Dimethyl{bis[(4,8,8-trimethyldecahydro-1,4 methanoazulen-9-y) C32H56O2 500 
41 56.873 3.91 IsoLongifolol C15H26O 222 
  100.00    
 
Methanolic leaves extract of D. viscosa indicates fifty 
two constituents. There are five major constituents were 
present likely 7-methanoazulen-6-ol, Alpha-Methyl 
gluco furanoside, Pregn-4-Ene-3, 20-Dione, Palmitic 
acid and Alpha-Ionol. Based on GC-MS spectrum 
confirmed the compounds with retention time 39.058, 
27.459, 35.870, 37.685 and 26.577 respectively (Figure 
3). Apart from the above mentioned compounds, the 7-
methanoazulen-6-ol, Alpha-Methyl gluco furanoside, 
Pregn-4-Ene-3, 20-Dione was containing the percentage 
of 28.32, 20.00 and 10.54. The 7-methanoazulen-6-ol 
was identified as active compound of the species D. 
viscosa. The molecular formula of the compound was 
C15H26O (Table 3). 
 
 
Figure 3: GC-MS Chromatogram of methanolic Leaf extract of D.viscosa 
 
Table 3: GC-MS report of methanolic Leaf extract of D. viscosa 
Peak 
 
R. 
Time 
Area% 
 
Name of the Compounds   Molecular 
Formula 
M.W. 
1 6.886 0.36 Monomethylmalonate C4H6O4 118 
2 9.901 0.28 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-methyl- C6H8O4 144 
3 11.724 0.22 2,3-Dihydro-Benzofuran C8H8O 120 
4 13.964 0.15 2-Methoxy-4-Vinylphenol C9H10O2 150 
5 19.288 0.14 3',5'-Dimethoxyacetophenone C10H12O3 180 
6 19.706 0.43 2,3-Di-O-methyl-D-xylopyranose C7H14O5 178 
7 20.603 0.14 Megastigmatrienone C13H18O 190 
8 21.954 0.28 2H-1-Benzopyran-5-ol, 3,4-Dihydro-2,2-dimethyl- C11H14O2 178 
9 23.046 0.09 Tetradecanoic acid C14H28O2 228 
10 24.043 0.47 2,4,6-Cycloheptatrien-1-one, 2-Hydroxy-5-(3-Methyl-2-But C15H18O2 230 
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11 24.443 0.31 2,6,10-Trimethyl,14-Ethylene-14-Pentadecne C20H38 278 
12 25.932 0.27 Hexadecanoic Acid, Methyl Ester C17H34O2 270 
13 26.577 5.91 Palmitic acid C16H32O2 256 
14 27.459 20.00 Alpha-Methylglucofuranoside C7H14O6 194 
15 28.100 0.05 Heptadecamonoenoic Acid C17H32O2 268 
16 28.309 1.67 Diallylphenylvinylsilane C14H18 214 
17 28.608 0.08 9,12-Octadecadienoic acid (Z,Z)-, methyl ester C19H34O2 294 
18 28.698 0.24 9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)- C19H32O2 292 
19 28.881 0.89 Phytol C20H40O 296 
20 29.222 0.44 9,12-Octadecadienoic acid (Z,Z)- C18H32O2 280 
21 29.334 1.63 Dichloroacetic acid, tridec-2-ynyl ester C15H24Cl2O2 306 
22 29.486 1.45 (3aS,4R,7R)-1,4,9,9-Tetramethyl-5,6,7,8-tetrahydro-4H-3a,7-
methanoazulene 
C15H22 202 
23 29.662 0.29 Octadecanoic acid C18H36O2 284 
24 29.943 0.08 (1R,4aR,4bS,7S,10aR)-1,4a,7-Trimethyl-7-vinyl-
1,2,3,4,4a,4b,5,6,7,8,10,10a- 
C20H30O 286 
25 31.752 0.41 Lup-20(29)-Ene-3,28-Diol, (3.Beta.)- C30H50O2 442 
26 32.951 0.23 Benzene, Hexaethyl- C18H30 246 
27 33.394 2.49 Cycloprop[e]indene-1a,2(1H)-dicarboxaldehyde, 3a,4,5,6,6a,6b-
hexahydro-5,5,6b- 
C15H20O2 232 
28 34.557  0.06 Cyclopropanecarboxylic acid, 2-[4-(1,1-dimethylethyl)phenyl]-, 
ethyl ester- 
C16H22O2 246 
29 34.736 1.87 Pregn-5-en-20-one, 3-(acetyloxy)-16,17-epoxy-6-methyl-, 
(3.beta.,16.alpha.)- 
C24H34O4 386 
30 35.106 1.15 4,5-Secocholest-6-en-4-oic acid, 5-oxo- C27H44O3 416 
31 35.497 0.16 5-Isopropylidene-6-methyldeca-3,6,9-trien-2-one C14H20O 204 
32 35.870 10.54 Pregn-4-Ene-3,20-Dione, 14-Hydroxy- C21H30O3 330 
33 36.036 2.26 Costunolide C15H20O2 232 
34 36.384 0.88 Bicyclo[5.3.0]decane, 2-methylene-5-(1-methylvinyl)-8-methyl- C15H24 204 
35 37.130 0.87 2(1H)-Naphthalenone, 4A,5,6,7,8,8A-Hexahydro-6-[1-
(Hydroxymethyl) 
C15H22O2 234 
36 37.685 4.87 Alpha-Ionol C13H22O 194 
37 39.058 28.32 7-methanoazulen-6-ol C15H26O 222 
38 39.179 1.25 Decahydronaphtho[2,3-b]furan-2-one, 3-[[2-(1H-imidazol-4-
yl)ethylamino]methyl]- 
C20H29N3O2 343 
39 39.313 0.64 4,14-Dimethyl-11-isopropyltricyclo[7.5.0.0(10,14)]tetradec-4-
en-8-one 
C19H30O 274 
40 39.520 0.16 5-(3-Buten-1-Ynyl)-2,2'-Bithienyl C12H8S2 216 
41 39.575 0.12 7-Methoxy-3-(4-pentylcyclohexyl)-1,2-dihydronaphthalene C22H32O 312 
42 39.846 1.76 Pregnan-20-one, 3,5-dihydroxy-6-methyl-, 
(3.beta.,5.alpha.,6.beta.)- 
C22H36O3 348 
43 42.226 0.26 Spiro(9,9'-Bis(2-Methyl-9H-Fluorene)) C15H25I 332 
44 42.407 0.10 (R)-6-Methoxy-2,8-dimethyl-2-((4R,8R)-4,8,12-
trimethyltridecyl)chroman 
C27H20 344 
45 42.568 0.11 .gamma.-Tocopherol C28H48O2 416 
46 43.337 0.16 Ethyl 5,8,11,14,17-icosapentaenoate C22H34O2 330 
47 43.415 1.49 Vitamin E C29H50O2 430 
48 43.996 0.81 (3S,3aR,6R,8aS)-7,7-Dimethyl-8-methyleneoctahydro-1H-3a,6-
methanoazulene- 
C15H22O 218 
49 44.976 1.10 Stigmasterol C29H48O 412 
50 45.820 0.85 .gamma.-Sitosterol C29H50O 414 
51 46.709 0.44 25-Homo-24-Ketocholesterol C28H46O2 414 
52 47.709 0.77 2,2-Dimethylcholest-7-En-3-Ol C29H50O 414 
  100.00    
 
FT-IR 
FT-IR range was utilized to distinguish the utilitarian 
gathering of the dynamic segments in view of the peak 
an incentive in the point of infrared radiation. The FT-
IR analysis results showed that the methanolic stem 
extract of C. quadrangularis having the presence of 
Alcohol, Aldehyde, Iso cyanides, Alkane, Primary 
alcohol, Chloro constituent (Table 4), which shows 
major peaks at 3420.91, 2924.27, 2846.85, 2076.74, 
1647.04, 1454.75, 1409.96, 1053.44, 1032.56, 1017.56, 
718.75 and 666.26 respectively (Figure 4). The FT-IR 
analysis of methanolic leaves extract of C. halicacabum, 
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the presence of Alcohol, Iso cyanides, Alkyl Compound, 
Alkane, Primary alcohol, Chloro constituent (Table 5). 
Constituent which shows major peaks at 3402.43, 
2926.05, 2226.24, 2077.15, 1644.48, 1454.30, 1412.48, 
1055.44, 1033.07, 1018.25, 906.19 and 655.71 
respectively (Figure 5). The FT-IR analysis methanolic 
leaves extract of D. viscosa showed Alcohol, Aldehyde, 
Nitrite, Alkane, Primary alcohol (Table 6). Constituent 
which shows high peaks at 3336.61, 2835.87, 1650.80, 
1451.41, 1263.33 and 1018.19 (Figure 6). 
 
 
Figure 4: FT-IR Spectrum of methanolic Stem extract of C. quadrangularis 
 
Figure 5: FT-IR Spectrum of methanolic Leaf extract of C. halicacabum 
 
Figure 6: FT-IR Spectrum of methanolic Leaf extract of D.viscosa 
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Table 4: FT-IR absorption and functional groups of Stem extract of C. quadrangularis 
S. No Wave No. Molecular Motion Functional group Absorption intensity 
1 3420.91cm-1 O-H Alcohol Strong 
2 2924.27 cm-1 O-H Alcohol Medium 
3 2846.85 cm-1 C=O Aldehyde Weak 
4 2076.74 cm-1 C=N Iso cyanides Medium 
5 1647.04 cm-1 O-NO Nirite Strong 
6 1454.75 cm-1 C-H Alkane Medium 
7 1409.96 cm-1 C-H Alkane Medium 
8 1053.44 cm-1 C-O Primary alcohol Strong 
9 1032.56 cm-1 C-O Primary alcohol Strong 
10 1017.56 cm-1 C-O Primary alcohol Strong 
11 718.75 cm-1 C-Cl Chloro compound Strong 
12 666.26 cm-1 C-Cl Chloro compound Strong 
 
Table 5: FT-IR absorption and functional groups of Leaf of C. halicacabum 
S. No Wave No. Molecular Motion Functional group Absorption intensity 
1 3402.53 cm-1 O-H Alcohol Strong 
2 2926.05 cm-1 O-H Alcohol Medium 
3 2226.24 cm-1 C=N Iso cyanides Medium 
4 2077.15 cm-1 C=N Iso cyanides Medium 
5 1644.48 cm-1 C=N Alkyl compound Strong 
6 1454.30 cm-1 C-H Alkane Medium 
7 1412.48 cm-1 C-H Alkane Medium 
8 1055.44 cm-1 C-O Primary alcohol Strong 
9 1033.07 cm-1 C-O Primary alcohol Strong 
10 1018.25 cm-1 C-O Primary alcohol Strong 
11 906.19 cm-1 C-O Primary alcohol Strong 
12 655.71 cm-1 C-Cl Chloro compound Strong 
 
Table 6: FT-IR absorption and functional groups of Leaf of D. viscosa 
S. No Wave No. Molecular Motion Functional group Absorption intensity 
1 3336.61cm-1 O-H Alcohol Strong 
2 2933.73 cm-1 O-H Alcohol Medium 
3 2835.87 cm-1 C=O Aldehyde Weak 
4 1650.80 cm-1 O-NO Nitrite Strong 
5 1451.41 cm-1 C-H Alkane Medium 
6 1263.33 cm-1 C-O Alcohol  Medium  
7 1018.19 cm-1 C-O Primary alcohol Strong 
 
The biological therapeutic activities of identified major 
components of the stem extract of C. quadrangularis, 
leaves extracts of C. halicacabum and D. viscosa were 
given in Table 7. Therapeutic activities of these major 
components analysed by using Dr. Duke’s 
Phytochemical and Ethno botanical data bases 
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Table 7: Therapeutic activity of major compounds in C. quadrangularis, C. halicacabum and D. viscosa 
S. 
No  
Name of the 
Compound  
Compound 
Nature 
Therapeutic activity 
1  3-O-Methyl-d-glucose Alcohol  Osteoporosis, anaesthetics, anti-epileptics, anti-convulsants and 
anti-parkinson drugs. 
2 D-Allose Allose Treating wounds, ulcers, burns, scars, keloids, anti-pruritic, anti-
psoriatic, arthritis and carthorses. 
3 9,12,15-Octadecatrienoic 
acid 
Fatty acid Anti-psoriatic, joint disorders, anti-pyretic, anti-inflammatory, 
wounds healing, anti-Tumor activities. 
4 Phytol Acyclicditerpene 
alcohol  
Anti-tubercular activity, allergic disorders and anti-microbial 
activities. 
5 Pentadecanoic Acid Fatty acid Anti-cancer drug, anti-asthmatics and anti-abortive. 
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6 Calix[4]arene Calixarene Anti-cancer (cancer immunotherapy) 
7 Epi-Psi-Taraxastanonol Terpenoids Cardiovascular disease 
8 Beta-Sitosterol Sterol Swelling, bladder infections, urinary tract infections, anti-
carcinogenic and anti-atherogenic properties, Anti-asthmatics 
and throat disorders. 
9 Tetradecanoic acid Fatty acid Antitumor activity, anti-spasmodic, anti-asthmatics and throat 
disorders.  
10 IsoLongifolol Ketone  Anti-microbial activities and anti-inflammatory 
11 7-methanoazulen-6-ol Alcohol  Anti-perspirants and anti-pruritic 
12 Alpha-
Methylglucofuranoside 
Glycoside  
 
Treating bacterial and, fungal infections, anti-abortive, anti-
bacterial, anti-viral and allergic disorders. 
13 Pregn-4-Ene-3,20-Dione Steroid  Sexualdisorders,baldness, anti-psoriatic, anti-pyretic, anti-
inflammatory, Anti-bacterial and Anti-allergic. 
14 Palmitic acid Fatty acid Throat disorders,anti-asthmatics, anti-pruritic, anti-psoriatic, 
anti-epileptics, anti-convulsantsand anti-migraine.  
15 Alpha-Ionol Alcohol  Anti-diabetics and anti-perspirants. 
Source: J. A. Duke (1992) Database of Biologically Active Phytochemicals
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CONCLUSION 
In the present study, the GC-MS analysis of the 
methanolic extract of C. quadrangularis, C. 
halicacabum and D. viscosa majorly present of fifteen 
compounds. Such as 3-O-Methyl-D-glucose, D-Allose, 
9,12,15-Octadecatrienoic acid, Phytol, Pentadecanoic 
acid. Calix [4] arene, Epi-.Psi.- Taraxastanonol, Beta-
Sitosterol,Tetradecanoic acid and Iso Longifolol,7-
methanoazulen-6-ol, Alpha-Methylglucofuranoside, 
Pregn-4-Ene-3, 20-Dione, Alpha-Ionol and Palmitic 
acid. Presence of these compounds were justifies, 
wounds healing, arthritis, anti-inflammatory Anti-
tubercular activity anti-microbial activities, anti-
asthmatics, throat disorders, Sexual disorders, baldness, 
Anti-cancer drug and other pharmacological activities. 
We report the presence of some of the significant 
components decided by GC-MS analysis, FT-IR 
analysis. From these results, it could be concluded that 
C. quadrangularis, C. halicacabum and D. viscosa 
contains different bioactive compounds. Assessment of 
pharmacological activity is under progress. Hence, it is 
prescribed as a plant of Phyto pharmaceutical 
significance.
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